Investigating the Pre‐Implementation Facilitators and Barriers of the Implementation of the Fear of Recurrence Therapy (FORT) Intervention in Canadian Cancer Centers
Sophie Lebel(University of Ottawa), Linda E. Carlson(University of Calgary), Sheila N. Garland(Memorial University of Newfoundland), Cheryl Harris(University of Ottawa), Robin Urquhart(Dalhousie University), Ghizlène Sehabi(University of Ottawa), Sara Beattie, Jacqueline L. Bender(University of Toronto), Agnihotram V. Ramanakumar(McGill University Health Centre), Christine Maheu(University Health Network), Jennifer M. Jones(Hospital for Sick Children), Alanna Chu(University of Ottawa), Claudia Hernández(Canadian Patient Safety Institute), Josée Savard(Centre hospitalier de l'Université Laval), Emma Kearns(University of Ottawa), Florence Gourgues(University of Ottawa), America Prudent(University of Ottawa), Yasmine W. Sehabi(University of Ottawa), Andrea Feldstain(University of Ottawa)
Cited by 1
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients
|International Journal of Behavioral Medicine|2005|556